DELIVER: Investigating the efficacy of nivolumab treatment in gastric cancer

Bookmark and Share
Published: 13 Jul 2020
Views: 319
Rating:
Save
Prof Yu Sunakawa - St. Marianna University School of Medicine, Kawasaki, Japan

Prof Yu Sunakawa speaks to ecancer in an online interview for the virtual ESMO GI 2020 meeting.

He explains the rationale behind the DELIVER trial, which is a large observational/translational study investigating the efficacy of nivolumab treatment in gastric cancer.

Prof Sunakawa outlines the design of this study, which incorporates real-world data to also identify novel biomarkers in this patient population.

He discusses the encouraging results, and the main conclusions of this study.